Launching Innovation Challenge with CSL Behring and Cicada Innovations

Date Posted – 14 April 2021
Applications Closed – 25 May 2021

Cicada Innovations and CSL Behring earlier today, launnched an Innovation Challenge to unearth solutions that will improve the production of Immunoglobulin G to meet growing global demand. This is an open call for solutions or ideas that will create impact, big or small, in plasma production. CSL Behring and Cicada Innovations are encouraging participants with commercially-viable solutions from any background and from across the world to apply.

This is a rare opportunity to get your idea in front of one of the world’s leading biotech companies and to receive funding of up to $40,000.

Applications close 25 May – find out more here


News & opinion

Member Directory